Enzolytics Inc (ENZC)

[OTCShotCaller]

Well said! The Biotech Cytodyn (CYDY) is one of them! Take a look at their 52-Week PPS History, i.e. $0.26 to $10 with ZERO product on the market, ZERO earnings, and still in the clinical trials phase!

But what they do have is a BigPharma partner for conducting Clinical Trials and taking their product to commercialization for their Clone Antibody Leronlimab (PRO 140 ) for treatment of HIV, which doesn't even come close to comparing to BioClonetics Clone 3 Ab.

Also Cytodyn's treatment application is NOT monotherapy like Clone 3, but instead it REQUIRES dual administration with the weekly Standard of Care regime (HAART), which can be up to 3X per week or more and it's associated with major side effects and prolonged co-morbidity and development of serious secondary clinical conditions that can be life threatening.

Their Ab has no reported side effects, BUT the HAART HIV standard of care tandem administration does which can be severe in many patients. And not only this, patient viral load is not cleared, but only reduced by up by to 80% in some patients.

Therefore CytoDyn does NOT have a curative treatment with their Antibody unlike BioClonetics Clone 3, AND it's NOT proven to be effect on most strains of HIV like Clone 3 is!

My point??? BioClonetics runs circles around Cytodyn but yet within the past 52 weeks their stock price SOARED up to $10, although it is presently trading in the $2 range. This range is where BioClonetics-Enzlytics should be trading right now just based on what they have!